Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 622,479 | 801,224 | +178,745 | $4.76M | $68.02M | 14.92% | +$63.26M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 3,260,570 | 4,604,878 | +1,344,308 | $20.90M | $62.58M | 13.72% | +$41.68M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 206,952 | 300,610 | +93,658 | $21.96M | $39.62M | 8.69% | +$17.66M |
| Dyne Therapeutics, Inc.(DYN) | 1,455,429 | 2,674,469 | +1,219,040 | $13.86M | $33.83M | 7.42% | +$19.98M |
| Cogent Biosciences, Inc.(COGT) | 2,297,524 | 2,025,041 | -272,483 | $16.50M | $29.08M | 6.38% | +$12.58M |
| Vaxcyte, Inc.(PCVX) | 544,221 | 788,441 | +244,220 | $17.69M | $28.40M | 6.23% | +$10.71M |
| Celcuity Inc.(CELC) | 1,185,520 | 473,828 | -711,692 | $15.83M | $23.41M | 5.13% | +$7.58M |
| CG Oncology, Inc.(CGON) | 586,647 | 579,895 | -6,752 | $15.25M | $23.36M | 5.12% | +$8.11M |
| Disc Medicine, Inc.(IRON) | 396,115 | 340,897 | -55,218 | $20.98M | $22.53M | 4.94% | +$1.55M |
| Pharvaris N V COM | 0 | 886,332 | +886,332 | $0 | $22.11M | 4.85% | +$22.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 468,364 | 503,701 | +35,337 | $14.66M | $20.22M | 4.44% | +$5.56M |
| Centessa Pharmaceuticals PlcADS | 793,327 | 734,539 | -58,788 | $10.42M | $17.81M | 3.91% | +$7.39M |
| Merus N V | 224,260 | 184,135 | -40,125 | $11.80M | $17.34M | 3.80% | +$5.54M |
| LENZ Therapeutics, Inc.(LENZ) | 342,312 | 368,176 | +25,864 | $10.03M | $17.15M | 3.76% | +$7.12M |
| Ocular Therapeutix, Inc.(OCUL) | 728,576 | 1,151,686 | +423,110 | $6.76M | $13.46M | 2.95% | +$6.70M |
| Monopar Therapeutics Inc.(MNPR) | 0 | 155,370 | +155,370 | $0 | $12.69M | 2.78% | +$12.69M |
| Newamsterdam Pharma Company ORDINARY SHARES | 220,695 | 153,147 | -67,548 | $4.00M | $4.36M | 0.96% | +$358.7K |
| argenx SEADR(ARGX) | 10,285 | 0 | -10,285 | $5.67M | $0 | — | -$5.67M |
| Ascendis Pharma A/SADR(ASND) | 38,191 | 0 | -38,191 | $6.59M | $0 | — | -$6.59M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 319,348 | 0 | -319,348 | $1.27M | $0 | — | -$1.27M |
| Kalvista Pharmaceuticals Inc | 62,793 | 0 | -62,793 | $709.9K | $0 | — | -$709.9K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 290,784 | 0 | -290,784 | $13.73M | $0 | — | -$13.73M |
| Neurocrine Biosciences, Inc.(NBIX) | 58,181 | 0 | -58,181 | $7.31M | $0 | — | -$7.31M |
| Replimune Group, Inc.(REPL) | 128,917 | 0 | -128,917 | $1.20M | $0 | — | -$1.20M |
| Silence Therapeutics plcADS(SLN) | 34,737 | 0 | -34,737 | $201.5K | $0 | — | -$201.5K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 500,551 | 0 | -500,551 | $4.69M | $0 | — | -$4.69M |